Open Access Open Access  Restricted Access Subscription Access

DESIGN AND IVIVC OF LAMIVUDINE TRANSDERMAL PATCHES

DR. R. NATARAJAN

Abstract


The transdermal drug delivery system for lamivudine was created utilising the solvent casting method with Span-80 acting as a permeation enhancer. The drug: polymer ratios (Lamivudine: HPMC and Lamivudine: EC) were created in two different ways: one at a ratio of 1:2.5, one at a ratio of 1:5, and one with permeation enhancers. The transdermal patch that was developed had good physical and chemical characteristics, did not cause any skin irritation in the rat skin, and was used in an in vitro drug permeation investigation where the rat skin was kept in phosphate buffer pH 7.4 for a full day. ANOVA's comparative statistical analytical data revealed a 'p' value of less than 0.0001, indicating the high significance of the produced formulation for transdermal distribution. The formulation (FPE2) ratio 1:5 of the patch containing a permeation enhancer and lamivudine: HPMC had the best outcome of all the formulations.


Full Text:

PDF

References


Ratan Mehta. “Topical and transdermal drug delivery”: What a Pharmacist need to know. ACEP; 1-10.

Joint united nations programme on HIV/AIDS (ON AIDS) and WHO” AIDS epidemic update 2005”, Geneva http://www.Unaids.org.

Roopa pai S. and Kusum Devi V. “Lamivudine liposomes for transdermal delivery formulation, Characterization, Stability and Invitro Evaluation”. International journal of pharmaceutical sciences and nanotechnology Volume 1. Issue 4. January – March 2009 p317-326.

Gupta Ritu, Bajpai Meenakshi, Bhattaracharya Arundhati. “Formulation and invitro evaluation of transdermal drug delivery system of Tizanidine hydrochloride” Journal of pharmaceutical research.2008;7(4):p208-213.

G.S. Sanap,G.Y.Dama, “Preparation of transdermal monolithic systems of indapamide by solvent casting method and the use of vegetable oils as permeation enhancer” International journal of green pharmacy, April – June,2008,p129- 133.

Rathore RPS, Chauhan C S, Naruka P S, Tanwar Y S and Chauhan L S. “Transdermal formulation of Terbutaline sulphate”. Pharmacy On-Line, April 2006. www.priory.com.

Yuveraj Singh Tanwar, Chetan Singh Chauhn, Anshu Sharma. “Development and Evaluation of Carvedilol Transdermal patches”. Acta Pharm. 57(2007)p151-59.

Janardhanan Bagyalakshmi, Ramachandra Purapu Vamsikrishna, Rajappan Manavalan, Thengungal Kochupappy Ravi and Probal Kumar Manna. “Formulation Development and in vitro and in vivo Evaluation of Membrane Moderated Transdermal Systems of Ampicillin Sodium in Ethanol: ph 4.7 Buffer Solvent System”. AAPS PharmSciTech.2007; 8 (1) Article 7. http://www.aapspharmscitech.org.

Jianping Wang, Jinlan Ruan,Changgog Zhang, Yujie Ye, Yaling Cai and Yanxia Wu. “Development and Evaluation of the Sinomenin Transdermal patch”. Pak. J. Pharm. Sci., Vol.21, No.4, October 2008,p407-410.

V kasum Devi, S saisivam G R maria “Design and evaluation of matrix controlled transdermal patch of verpamil Hcl” Drug development and industrial pharmacy 2003.vol-29 NO5 page-503.


Refbacks

  • There are currently no refbacks.